CCS
Concentric Capital Strategies’s Boston Scientific BSX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-40,448
| Closed | -$4.08M | – | 260 |
|
|
2025
Q1 | $4.08M | Buy |
+40,448
| New | +$4.08M | 0.38% | 43 |
|
|
2024
Q4 | – | Sell |
-96,363
| Closed | -$8.08M | – | 257 |
|
|
2024
Q3 | $8.08M | Buy |
96,363
+53,993
| +127% | +$4.52M | 0.33% | 49 |
|
|
2024
Q2 | $3.26M | Buy |
42,370
+10,058
| +31% | +$775K | 0.16% | 125 |
|
|
2024
Q1 | $2.21M | Sell |
32,312
-19,421
| -38% | -$1.33M | 0.12% | 165 |
|
|
2023
Q4 | $2.99M | Buy |
+51,733
| New | +$2.99M | 0.34% | 72 |
|
|
2022
Q4 | – | Sell |
-58,112
| Closed | -$2.25M | – | 145 |
|
|
2022
Q3 | $2.25M | Buy |
+58,112
| New | +$2.25M | 0.79% | 42 |
|